Skip to content

Arrowhead Pharmaceuticals

US · ARWR #1569 by market cap Listed 1970
41.37 -2.28 -5.22%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
C-
Momentum strategy signal
Sell
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Morgan Stanley moved from Hold to Buy on 2026-04-21.

Analyst consensus 11 analysts

Buy
Avg price target 106.63 +157.7%
Price target rangecurrent 41.37
Low74.00
Avg106.63
High126.00
Buy 91% Hold 9% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-13 Piper Sandler -- Buy 126.00
2026-11-13 BofA Securities -- Buy --
2026-11-13 Morgan Stanley -- Buy 106.00
2026-11-13 Stifel -- Buy 96.00
2026-11-13 RBC Capital -- Buy 100.00
2026-11-11 H.C. Wainwright -- Buy 120.00
2026-11-10 Piper Sandler -- Buy 126.00
2026-11-10 B. Riley Securities -- Buy 123.00
2026-11-05 H.C. Wainwright -- Buy 120.00
2026-10-15 Piper Sandler -- Buy 126.00
2026-10-15 H.C. Wainwright -- Buy 120.00
2026-10-15 J.P. Morgan -- Buy --
2026-10-14 Citi -- Buy 108.00
2026-10-14 H.C. Wainwright -- Buy 120.00
2026-10-12 BofA Securities -- Buy 100.00
2026-09-24 Goldman Sachs -- Hold 74.00
2026-09-21 H.C. Wainwright -- Buy 120.00
2026-09-16 Citi -- Buy --
2026-09-15 J.P. Morgan -- Buy --
2026-09-09 Citi -- Buy 108.00
2026-09-08 Citi -- Buy 108.00
2026-09-01 H.C. Wainwright -- Buy 120.00
2026-08-31 Morgan Stanley -- Buy 120.00
2026-08-31 Stifel -- Buy 104.00
2026-08-31 J.P. Morgan -- Buy --

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-04-21 Morgan Stanley Hold → Buy 100.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q4 2026-11-12 After close ±8.47% +1.34% (in line)
2026/Q3 2026-08-04 After close ±8.92% -2.99% (in line)
2026/Q2 2026-05-07 After close ±7.25% -6.75% (in line)
2026/Q1 2026-02-05 After close ±11.93% -0.19% (in line)
2025/Q4 2025-11-25 After close ±13.52% +23.34% (beat)
2025/Q3 2025-08-07 After close ±13.30% +2.24% (in line)
2025/Q2 2025-05-12 After close ±11.99% +9.38% (in line)
2025/Q1 2025-02-10 After close ±10.83% -5.17% (in line)
2024/Q4 2024-11-26 After close ±15.02% +24.23% (beat)
2024/Q3 2024-08-08 After close ±12.75% -9.44% (in line)
2024/Q2 2024-05-09 After close ±10.35% -10.68% (beat)
2023/Q4 2023-11-29 After close ±12.00% -26.85% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Arrowhead Pharmaceuticals discussion 0 comments

Add a comment